| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S40291-018-0325-0 |
| P698 | PubMed publication ID | 29556924 |
| P50 | author | Carmen Pheiffer | Q42445356 |
| Stephanie Dias | Q58494207 | ||
| P2093 | author name string | Paul Rheeder | |
| Sumaiya Adam | |||
| P2860 | cites work | Most mammalian mRNAs are conserved targets of microRNAs | Q24655061 |
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Regulatory mechanisms of microRNA expression | Q26747609 | ||
| Role of Extracellular Vesicles and microRNAs on Dysfunctional Angiogenesis during Preeclamptic Pregnancies | Q26752382 | ||
| Gestational diabetes mellitus in Africa: a systematic review | Q27000199 | ||
| Combinatorial microRNA target predictions | Q27860510 | ||
| Mammalian microRNAs predominantly act to decrease target mRNA levels | Q27860535 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells | Q28115799 | ||
| A Comparison of South African National HIV Incidence Estimates: A Critical Appraisal of Different Methods | Q28546966 | ||
| The offspring of the diabetic mother--short- and long-term implications. | Q30367313 | ||
| Data Normalization Strategies for MicroRNA Quantification | Q30997590 | ||
| Comparing the MicroRNA spectrum between serum and plasma | Q31080442 | ||
| FOXO transcription factors: their clinical significance and regulation. | Q33594004 | ||
| MicroRNA Expression Varies according to Glucose Tolerance, Measurement Platform, and Biological Source | Q33654397 | ||
| International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy | Q33683832 | ||
| Mother's Pre-pregnancy BMI and Placental Candidate miRNAs: Findings from the ENVIRONAGE Birth Cohort. | Q33911774 | ||
| Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus. | Q34009709 | ||
| Gestational diabetes mellitus alters apoptotic and inflammatory gene expression of trophobasts from human term placenta | Q34199711 | ||
| MiRNA 26a expression in a novel panel of African American prostate cancer cell lines | Q35053774 | ||
| Increased plasma levels of FABP4 and PTEN is associated with more severe insulin resistance in women with gestational diabetes mellitus | Q35087642 | ||
| Population differences in microRNA expression and biological implications | Q35578546 | ||
| Profiling maternal plasma microRNA expression in early pregnancy to predict gestational diabetes mellitus | Q35607933 | ||
| DIANA-miRPath v3.0: deciphering microRNA function with experimental support | Q35810103 | ||
| Serum MicroRNAs as Diagnostic Biomarkers for Macrosomia | Q35853196 | ||
| Gestational diabetes induces chronic hypoxia stress and excessive inflammatory response in murine placenta | Q36712010 | ||
| Determination of 14 circulating microRNAs in Swedes and Iraqis with and without diabetes mellitus type 2. | Q37534653 | ||
| Serum miR-20a is a promising biomarker for gastric cancer | Q37732033 | ||
| Diabetes mellitus, a microRNA-related disease? | Q37855088 | ||
| Screening for gestational diabetes mellitus in a South African population: Prevalence, comparison of diagnostic criteria and the role of risk factors | Q38730677 | ||
| MicroRNAs in Pregnancy and Gestational Diabetes Mellitus: Emerging Role in Maternal Metabolic Regulation | Q39220964 | ||
| Future risk of diabetes in mother and child after gestational diabetes mellitus | Q40009689 | ||
| HIV-1 Infection Dysregulates Cell Cycle Regulatory Protein p21 in CD4+ T Cells Through miR-20a and miR-106b Regulation | Q40836975 | ||
| Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy | Q41954466 | ||
| Differential expression of microRNAs in omental adipose tissue from gestational diabetes mellitus subjects reveals miR-222 as a regulator of ERα expression in estrogen-induced insulin resistance | Q42805720 | ||
| Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus. | Q46140729 | ||
| The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care | Q46193349 | ||
| Analysis of circulating microRNA: preanalytical and analytical challenges. | Q54378210 | ||
| Hsa-miR-222 is involved in differentiation of endometrial stromal cells in vitro. | Q54733722 | ||
| Detection and Characterization of Placental MicroRNAs in Maternal Plasma | Q58029285 | ||
| Secreted microRNAs: a new form of intercellular communication | Q83285061 | ||
| P921 | main subject | South Africa | Q258 |
| gestational diabetes | Q126691 | ||
| P577 | publication date | 2018-03-19 | |
| P1433 | published in | Molecular Diagnosis and Therapy | Q15758832 |
| P1476 | title | Decreased Expression of Circulating miR-20a-5p in South African Women with Gestational Diabetes Mellitus. |
| Q94464057 | Circulating Exosomal miRNA as Diagnostic Biomarkers of Neurodegenerative Diseases |
| Q93047774 | Diabetes in Pregnancy and MicroRNAs: Promises and Limitations in Their Clinical Application |
| Q98778890 | Expression of miR-409-5p in gestational diabetes mellitus and its relationship with insulin resistance |
| Q91828914 | Influence and mechanism of miR-99a suppressing development of colorectal cancer (CRC) with diabetes mellitus (DM) |
| Q91643863 | MicroRNA Signatures as Future Biomarkers for Diagnosis of Diabetes States |
| Q57149236 | Molecular Biomarkers for Gestational Diabetes Mellitus |
Search more.